What is Futerpenol®?

Futerpenol® is a 100% natural, non-pharmacological metabolic conditioning system developed by MNL Group for aquaculture. Based on Maqui Berry (Aristotelia chilensis) extract, it acts on the metabolic–inflammatory–oxidative axis to help fish maintain physiological balance under chronic production stressors such as temperature shifts, crowding, oxygen variation, and pathogen pressure.

What are the proven results of Futerpenol® in commercial salmon farming?

Over six years of field evaluations across 36 commercial salmon centers (~900,000 fish), Futerpenol® demonstrated: −44% total mortality over 90 days, −60% SRS (Piscirickettsiosis) mortality during active use, −15% mortality at cycle closure, −50% reduction in antibiotic use, −25% less intestinal damage, and +15% improvement in feed conversion ratio. Results validated by Pathovet, Aquabench, Universidad Austral de Chile (UACH), and Universidad Católica de Valparaíso (PUCV).

How does Futerpenol® reduce the need for antibiotics in aquaculture?

By strengthening fish immunity through increased CD8+ cytotoxic lymphocytes (+75%) and IL-12 cytokine expression (+50%), Futerpenol® improves biological resilience against bacterial pathogens such as SRS (Piscirickettsiosis). This reduces the need for reactive antibiotic treatments, contributing to antibiotic stewardship and alignment with global AMR reduction goals.

What products are included in the Futerpenol® line?

The Futerpenol® product line includes: Futerpenol® Feed Green (metabolic stability during key productive stages), FWXT® (metabolic adjustment during freshwater and transfer phases, with Maqui fraction), FuterCoho® (targeted support for Coho salmon, with Maqui fraction), and FutermaquiXT® (full production cycle redox and metabolic support, with Maqui fraction).

Is Futerpenol® safe and certified for commercial aquaculture use?

Yes. Futerpenol® is 100% natural and free from antibiotics, pesticides, heavy metals, dioxins, and furans. It is manufactured in Chile under GMP standards and independently verified by Multianálisis SpA, with full traceability across production batches.

Futerpenol®

Futerpenol® is a metabolic conditioning system designed to help fish maintain physiological balance under chronic production challenges such as temperature shifts, transfer, crowding, oxygen variation, and pathogen pressure.

By acting on the metabolic–inflammatory–oxidative axis, Futerpenol® supports better energy allocation, reduced physiological cost, and greater bioresilience throughout the production cycle.

Science, sustainability, and performance — working together to support bioresilient aquaculture.

Field evaluations show that Futerpenol™ produces a significant increase in cytotoxic lymphocyte activity and cytokine expression associated with immune activation, demonstrating that the product stimulates both innate and adaptive immunity. This translates into stronger resistance against bacterial and environmental stress, especially during critical production phases like transfer and smoltification.

Verified by Pathovet, 2017–2022.
Farms using Futerpenol™ consistently reported substantially lower total mortality during active use, indicating greater bioresilience and recovery capacity under environmental and operational stress.

Validated by Pathovet and UACH.
Futerpenol™ programs achieved markedly lower mortality during active use and sustained improvements through the end of the production cycle, reflecting more stable organismal performance over long-term challenges.

Source: Aquabench, 2022.
Cycle-closed evaluations revealed a significant reduction in antibiotic use among farms on Futerpenol™ programs, associated with more stable biological performance under production stressors — contributing to responsible antimicrobial practices.

Source: Aquabench, 2022.
Fish on Futerpenol™ programs showed measurable improvements in intestinal integrity and feed conversion, suggesting better nutrient absorption, reduced physiological stress, and more efficient use of nutritional resources throughout the production cycle.

Source: Pathovet, 2021.

Futerpenol® — Natural Metabolic Conditioning for Fish Health, Performance & Bioresilience

From Nature to Aquaculture Innovation

Product Line

Scientific Validation

Sustainability & Quality

Proven Results in Real Aquaculture Conditions

Improved Immune Response

Lower Mortality and Healthier Fish

Reduced SRS Mortality (Piscirickettsiosis)

Fewer Antibiotics, Healthier Oceans

Better Gut Health and Feed Efficiency

Partner with the Leaders in Maqui Berry Science